KPTI Karyopharm Therapeutics
- 1.030
- -0.070-6.36%
- 1.070
- +0.040+3.88%
Karyopharm Therapeutics News
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rangwala Reshma
Karyopharm Therapeutics | ARS: Annual Report to Security Holders
Karyopharm Therapeutics | DEFA14A: Others
Karyopharm Therapeutics | DEF 14A: Definitive information statements
Karyopharm Therapeutics | SC TO-C: Written communication relating to an issuer or third party tender offer
Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rangwala Reshma
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Sohanya Roshan
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Stuart
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rangwala Reshma
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Sohanya Roshan
Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.
Analysis
Price Target
No Data
